CVKD Cadrenal Therapeutics, Inc. - Common Stock
$4.97
价格 · 五月 20, 2026
截至...的财报数据 五月 7, 2026
52周区间
$4–$16
6% of range
分析师评级
BUY
8 analysts
目标价
$28
+457% upside
P/E (TTM)
-1.0
ROE
-376.2%
净利润率
—
CVKD 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$4.97
市值
$16M
P/E (TTM)
-1.0
每股收益 (TTM)
$-6.64
营收 (TTM)
—
股息收益率
—
ROE
-376.2%
负债/权益
—
52周区间
$4 – $16
CVKD 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
—
EPS
$-6.64
2022-12-31
→
2025-12-31
自由现金流
$-13M
2022-12-31
→
2025-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
CVKD
同行中位数
P/E (TTM)
-1.0
42.1
P/B (市净率)
5.8
2.1
Price / FCF (股价/自由现金流)
-1.3
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
CVKD
同行中位数
ROA
-183.2%
-71.6%
ROE
-376.2%
-62.0%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
CVKD
同行中位数
Current Ratio (流动比率)
2.7
2.3
Quick Ratio (速动比率)
2.5
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
CVKD
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
CVKD
同行中位数
CVKD 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
8 位分析师
- 强烈买入 2 25.0%
- 买入 5 62.5%
- 持有 1 12.5%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
3 位分析师 · 2026-05-19
中位数
$25.00
平均值
$27.67
← 低于所有目标
$4.97
最低
$13.00
最高
$45.00
中位数目标
$25.00
+403.0%
平均目标
$27.67
+456.7%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.17%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年3月31日 | $-1.04 | $-1.65 | 0.61% |
| 2025年12月31日 | $-1.43 | $-1.19 | -0.24% |
| 2025年9月30日 | $-1.31 | $-1.56 | 0.25% |
| 2025年6月30日 | $-1.87 | $-1.63 | -0.24% |
| 2025年3月31日 | $-2.09 | $-1.67 | -0.42% |
| 2024年12月31日 | $-2.74 | $-1.75 | -0.99% |
同行比较 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| CVKD | $16M | -1.0 | — | — | -376.2% | — |
| LPCN | $49M | -4.8 | -82.3% | -487.1% | -60.9% | — |
| JUNS | $35M | -4.1 | — | -39662.8% | 3516.1% | 80.6% |
| COCP | $14M | -1.3 | — | — | -151.4% | — |
| CTXR | — | -0.4 | — | — | — | — |
| HIND | $20M | -0.7 | 24.4% | -3209.7% | -411.1% | 68.4% |
| HOTH | $15M | -1.1 | — | — | -156.9% | — |
| KPRX | $7M | -0.7 | — | — | -56.6% | — |
| BFRI | — | — | — | — | — | — |
| CALC | — | -3.3 | -29.7% | — | — | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 13
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cost of Revenue | · | · | $220.1K | · | |
| R&D Expense | $4M | $4M | $4M | $392.9K | |
| SG&A Expense | $9M | $7M | $4M | $2M | |
| Operating Expenses | $13M | $11M | $8M | $3M | |
| Operating Income | $-13M | $-11M | $-8M | $-3M | |
| Interest Expense | · | · | · | $40.2K | |
| Other Non-op | $223.8K | $309.3K | $-724.2K | $-4M | |
| Net Income | $-13M | $-11M | $-8M | $-7M | |
| EPS (Basic) | $-6.64 | $-8.73 | $-9.29 | $-0.85 | |
| EPS (Diluted) | $-6.64 | $-8.73 | $-9.29 | $-0.85 | |
| Shares (Basic) | 1,993,757 | 1,219,550 | 899,465 | 7,890,507 | |
| Shares (Diluted) | 1,993,757 | 1,219,550 | 899,465 | 7,890,507 | |
| EBITDA | $-13M | $-11M | $-8M | $-3M |
资产负债表 18
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $10M | $8M | $32.6K | |
| Prepaid Expense | $200.1K | $42.3K | $52.4K | $22.7K | |
| Current Assets | $4M | $10M | $8M | $727.6K | |
| PP&E (Net) | $5.2K | $6.9K | $2.3K | $1.0K | |
| Other Non-current Assets | $2.2K | $3.8K | $3.8K | $6.0K | |
| Total Assets | $4M | $10M | $9M | $778.2K | |
| Accounts Payable | $650.7K | $2M | $167.3K | $404.9K | |
| Accrued Liabilities | $937.3K | $1M | $638.2K | $863.6K | |
| Short-term Debt | · | · | · | $43.7K | |
| Current Liabilities | $2M | $3M | $826.9K | $1M | |
| Capital Leases | · | · | · | $21.4K | |
| Total Liabilities | $2M | $3M | $826.9K | $6M | |
| Common Stock | $2.3K | $1.8K | $868 | $8.2K | |
| Paid-in Capital | $42M | $33M | $23M | $1M | |
| Retained Earnings | $-39M | $-26M | $-15M | $-7M | |
| Stockholders' Equity | $3M | $7M | $8M | $-6M | |
| Liabilities + Equity | $4M | $10M | $9M | $778.2K | |
| Shares Outstanding | 2,338,127 | 1,782,486 | 868,184 | 546,258 |
现金流 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $2M | $1M | $710.4K | $928.0K | |
| Operating Cash Flow | $-13M | $-7M | $-4M | $-1M | |
| CapEx | $5.1K | $6.5K | $3.3K | $2.3K | |
| Investing Cash Flow | $-5.1K | $-6.5K | $-3.3K | $-2.3K | |
| Stock Issued | $5M | $5M | · | $8.0K | |
| Net Stock Activity | $5M | $5M | · | $8.0K | |
| Financing Cash Flow | $7M | $9M | $12M | $1M | |
| Free Cash Flow | $-13M | $-7M | $-4M | $-1M |
盈利能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ROA | -183.2% | -114.3% | -179.8% | -1725.7% | |
| ROE | -376.2% | -196.3% | -101.7% | 199.5% |
流动性与偿付能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 2.7 | 3.8 | 10.3 | 0.5 | |
| Quick Ratio | 2.5 | 3.7 | 10.2 | · | |
| Interest Coverage | · | · | · | -67.2 |
估值 (TTM) 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Net Income TTM | $-13M | $-11M | $-8M | $-7M | |
| Market Cap | $16M | $26M | $145M | · | |
| P/E | -1.0 | -1.7 | -1.2 | · | |
| P/B | 5.8 | 3.5 | 18.8 | · | |
| P / Tangible Book | 5.8 | 3.5 | 18.8 | · | |
| P / Cash Flow | -1.3 | -3.5 | -40.9 | · | |
| P / FCF | -1.3 | -3.5 | -40.9 | · | |
| Earnings Yield | -97.9% | -60.2% | -83.7% | · |
损益表 13
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| R&D Expense | $771.5K | $666.3K | $688.5K | $1M | $2M | $2M | $784.6K | $1M | $629.0K | $361.1K | $243.9K | $241.0K | $3M | · | |
| SG&A Expense | $2M | $2M | $2M | $3M | $2M | $3M | $2M | $1M | $1M | $902.1K | $898.1K | $784.6K | $964.7K | $958.8K | |
| Operating Expenses | $3M | $3M | $3M | $4M | $4M | $4M | $2M | $2M | $2M | $1M | $1M | $1M | $4M | $1M | |
| Operating Income | $-3M | $-3M | $-3M | $-4M | $-4M | $-4M | $-2M | $-2M | $-2M | $-1M | $-1M | $-1M | $-4M | $-1M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | $3.5K | · | |
| Other Non-op | $17.8K | $26.1K | $48.1K | $67.0K | $82.6K | $91.2K | $52.1K | $73.6K | $92.3K | $119.8K | $106.1K | $23.2K | $-973.3K | · | |
| Net Income | $-2M | $-3M | $-3M | $-4M | $-4M | $-4M | $-2M | $-2M | $-2M | $-1M | $-1M | $-1M | $-5M | $-5M | |
| EPS (Basic) | $-1.04 | $-1.37 | $-1.31 | $-1.87 | $-2.09 | $-2.75 | $-2.18 | $-2.24 | $-1.56 | $-7.71 | $-1.01 | $-0.09 | $-0.48 | $-0.63 | |
| EPS (Diluted) | $-1.04 | $-1.37 | $-1.31 | $-1.87 | $-2.09 | $-2.75 | $-2.18 | $-2.24 | $-1.56 | $-7.71 | $-1.01 | $-0.09 | $-0.48 | $-0.77 | |
| Shares (Basic) | 2,407,665 | -3,855,990 | 2,044,033 | 1,961,642 | 1,844,072 | -2,018,917 | 1,104,005 | 1,067,231 | 1,067,231 | -22,622,197 | 1,026,415 | 11,722,754 | 10,772,493 | -15,366,711 | |
| Shares (Diluted) | 2,407,665 | -3,855,990 | 2,044,033 | 1,961,642 | 1,844,072 | -2,018,917 | 1,104,005 | 1,067,231 | 1,067,231 | -22,622,197 | 1,026,415 | 11,722,754 | 10,772,493 | -15,366,711 | |
| EBITDA | $-3M | · | $-3M | $-4M | $-4M | · | $-2M | $-2M | $-2M | · | $-1M | $-1M | $-4M | · |
资产负债表 18
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $4M | $4M | $6M | $7M | $10M | $4M | $5M | $7M | · | $9M | · | · | $32.6K | |
| Prepaid Expense | $428.1K | $200.1K | $116.0K | $358.4K | $575.6K | $42.3K | $191.7K | $234.9K | $293.8K | $52.4K | $168.6K | $289.3K | $410.9K | $22.7K | |
| Current Assets | $3M | $4M | $4M | $6M | $8M | $10M | $5M | $5M | $7M | $8M | $9M | $4M | $4M | $727.6K | |
| PP&E (Net) | $4.6K | $5.2K | $5.7K | $4.3K | $4.7K | $6.9K | $814 | $1.2K | $1.7K | $2.3K | $2.9K | $3.5K | $823 | $1.0K | |
| Other Non-current Assets | $2.2K | $2.2K | $2.2K | $2.2K | $3.8K | $3.8K | $3.8K | $3.8K | $3.8K | $3.8K | $3.8K | $3.8K | $3.8K | $6.0K | |
| Total Assets | $3M | $4M | $4M | $6M | $8M | $10M | $5M | $5M | $7M | $9M | $9M | $4M | $4M | $778.2K | |
| Accounts Payable | $824.8K | $650.7K | $614.1K | $895.6K | $1M | $2M | $496.8K | $759.5K | $400.4K | $167.3K | $141.7K | $78.1K | $119.6K | $404.9K | |
| Accrued Liabilities | $240.1K | $937.3K | $738.5K | $783.9K | $561.8K | $1M | $767.9K | $696.6K | $440.8K | $638.2K | $396.9K | $272.1K | $258.9K | $863.6K | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $43.7K | |
| Current Liabilities | $1M | $2M | $1M | $2M | $2M | $3M | $1M | $1M | $856.3K | $826.9K | $563.6K | $374.3K | $401.6K | $1M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | $2.2K | $8.8K | $15.2K | $21.4K | |
| Total Liabilities | $1M | $2M | $1M | $2M | $2M | $3M | $1M | $1M | $856.3K | $826.9K | $565.8K | $383.1K | $416.8K | $6M | |
| Common Stock | $2.5K | $2.3K | $2.1K | $2.0K | $1.9K | $1.8K | $1.2K | $16.0K | $16.0K | $868 | $13.0K | $11.7K | $11.7K | $8.2K | |
| Paid-in Capital | $43M | $42M | $39M | $38M | $36M | $33M | $25M | · | · | $23M | $23M | $16M | $16M | · | |
| Retained Earnings | $-41M | $-39M | $-36M | $-33M | $-30M | $-26M | $-22M | $-19M | $-17M | $-15M | $-14M | $-13M | $-12M | $-7M | |
| Stockholders' Equity | $2M | $3M | $3M | $4M | $6M | $7M | $3M | $4M | $6M | $8M | $9M | $3M | $4M | $-6M | |
| Liabilities + Equity | $3M | $4M | $4M | $6M | $8M | $10M | $5M | $5M | $7M | $9M | $9M | $4M | $4M | $778.2K | |
| Shares Outstanding | 2,506,817 | 2,338,127 | 2,059,754 | 2,007,113 | 1,909,732 | 1,782,486 | 1,234,672 | 16,008,469 | 16,008,469 | 868,184 | 13,022,754 | 11,722,754 | 11,722,754 | 8,193,875 |
现金流 8
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $252.4K | $325.1K | $473.4K | $592.6K | $548.8K | $763.2K | $300.0K | $193.1K | $162.7K | $103.1K | $153.1K | $167.8K | $286.4K | · | |
| Operating Cash Flow | $-3M | $-3M | $-2M | $-3M | $-5M | $-2M | $-2M | $-2M | $-2M | $-694.4K | $-627.8K | $-795.3K | $-1M | · | |
| CapEx | · | $0 | $1.9K | $0 | $3.3K | · | · | · | · | $0 | $1 | · | · | · | |
| Investing Cash Flow | · | $0 | $-1.9K | $0 | $-3.3K | · | · | · | · | $0 | $-1 | · | · | · | |
| Stock Issued | $-64.0K | $846.1K | $668.0K | $1M | $-85.3K | $4M | · | · | · | · | · | $0 | $5M | · | |
| Net Stock Activity | $-64.0K | · | · | · | $2M | · | · | · | · | · | · | · | $5M | · | |
| Financing Cash Flow | $1M | $3M | $648.4K | $1M | $2M | $7M | $2M | $0 | $298 | $-12.5K | $7M | $0 | $5M | · | |
| Free Cash Flow | · | · | · | · | $-5M | · | · | · | · | · | · | · | · | · |
盈利能力 2
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -46.2% | · | -61.3% | -64.1% | -51.3% | · | -34.4% | -53.1% | -28.8% | · | -22.3% | -56.4% | -230.9% | · | |
| ROE | -63.1% | · | -87.4% | -88.5% | -62.5% | · | -39.6% | -66.8% | -32.4% | · | -23.7% | -63.2% | -254.5% | · |
流动性与偿付能力 3
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.7 | · | 3.0 | 3.6 | 4.3 | · | 3.7 | 3.7 | 8.2 | · | 16.5 | 9.4 | 11.1 | · | |
| Quick Ratio | 2.2 | · | 2.9 | 3.3 | 4.0 | · | 3.4 | 3.4 | 7.7 | · | 16.2 | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | -1188.5 | · |
估值 (TTM) 8
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-13M | · | $-13M | $-12M | $-10M | · | $-8M | $-6M | $-9M | · | $-8M | $-8M | $-7M | · | |
| Market Cap | $13M | · | $28M | $24M | $34M | · | $17M | $113M | $146M | · | $133M | $266M | $248M | · | |
| P/E | -0.8 | · | -1.9 | -1.4 | -2.2 | · | -2.0 | -1.4 | -2.9 | · | -6.0 | -36.0 | -37.8 | · | |
| P/B | 7.1 | · | 10.4 | 5.6 | 5.5 | · | 4.9 | 28.3 | 23.7 | · | 15.2 | 83.6 | 61.0 | · | |
| P / Tangible Book | 7.1 | · | 10.4 | 5.6 | 5.5 | · | 4.9 | 28.3 | 23.7 | · | 15.2 | 83.6 | 61.0 | · | |
| P / Cash Flow | -4.3 | · | · | · | -7.2 | · | · | · | -79.8 | · | · | · | -175.5 | · | |
| P / FCF | · | · | · | · | -7.2 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -123.2% | · | -53.9% | -69.5% | -45.8% | · | -51.2% | -69.5% | -34.3% | · | -16.8% | -2.8% | -2.6% | · |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| 净收入 | $-13M | $-11M | $-8M | $-7M |
| 稀释后每股收益 (EPS) | $-6.64 | $-8.73 | $-9.29 | $-0.85 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| 流动比率 | 2.7 | 3.8 | 10.3 | 0.5 |
| 速动比率 | 2.5 | 3.7 | 10.2 | — |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| 自由现金流 | $-13M | $-7M | $-4M | $-1M |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。